{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:59:28Z","timestamp":1782781168843,"version":"3.54.5"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Impairment of the innate immune function may contribute to the increased risk of bacterial and viral infections in people with HIV (PWH). In this study we aimed to investigate the induced innate immune responses in PWH prior to and after initiation of combinational antiretroviral therapy (cART). Furthermore, we aimed to investigate if the induced innate immune responses before initiation of cART were associated with CD4+ T-cell recovery one year after initiating cART.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and method<\/jats:title><jats:p>The induced innate immune response was assessed by the TruCulture<jats:sup>\u00ae<\/jats:sup>whole blood technique in 32 PWH before cART initiation and after 1, 6 and 12 months. To mimic bacterial and viral infections we used a panel of three stimuli (lipopolysaccharide (LPS), resiquimod (R848), and polyinosinic:polycytidylic acid (Poly I:C)) to stimulate the extracellular Toll-like receptor (TLR) 4 and the intracellular TLR7\/8 and TLR3, respectively. The following cytokine responses were analyzed by Luminex 200: Tumor Necrosis Factor (TNF)-\u03b1, Interleukin (IL)-1b, IL-6, IL-8, IL-10, IL-12p40, IL17A, Interferon (IFN)-\u03b1, and IFN-\u03b3.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At baseline PWH with nadir CD4+ T-cell count &amp;lt;350 cell\/\u00b5L had lower levels of LPS-, R848-, and Poly I:C-induced IL-6 and IFN-\u03b3, LPS- and R848-induced TNF-\u03b1 and IL-12, LPS induced IL-1b, and R848-induced IL-10 than PWH with nadir CD4+ T-cell count &amp;gt;350 cells\/\u00b5L. The majority (&amp;gt;50%) had induced cytokine concentrations below the reference intervals at baseline which was most pronounced for the LPS- and Poly I:C-induced responses. The induced responses in the whole population improved after 12 months of cART, and more PWH had induced cytokine concentrations within the reference intervals after 12 months. However, the majority of PWH still had LPS-induced INF-\u03b1, INF-\u03b3 and Poly I:C-induced TNF-\u03b1 and IL-6 below the reference interval. The induced innate immune responses before cART initiation were not associated with the CD4+ T-cell recovery after 12 months of cART.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The innate immune response was impaired in PWH, with a more pronounced impairment in PWH with low nadir CD4+ T-cell count. Initiation of cART improved the innate immune response, but compared to the reference intervals, some impairment remained in PWH without viral replication.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.974767","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T08:40:24Z","timestamp":1660725624000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Improved induced innate immune response after cART initiation in people with HIV"],"prefix":"10.3389","volume":"13","author":[{"given":"Malene","family":"Hove-Skovsgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Leth","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemette","family":"Hald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gerstoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisse Rye","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne Dam","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV Infection","volume":"1","author":"Deeks","year":"2015","journal-title":"Nat Rev Dis Prim"},{"key":"B2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1468-1293.2012.01051.x","article-title":"Decreasing mortality and changing patterns of causes of death in the Swiss HIV cohort study","volume":"14","author":"Weber","year":"2013","journal-title":"HIV Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(16)30020-2","article-title":"Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort","volume":"2","author":"Croxford","year":"2017","journal-title":"Lancet Public Heal"},{"key":"B4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/cid\/cit596","article-title":"Community-acquired bacterial bloodstream infections in HIV-infected patients: A systematic review","volume":"58","author":"Mayer","year":"2014","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1615896","article-title":"HIV-Associated cancers and related diseases","volume":"378","author":"Yarchoan","year":"2018","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu1161","article-title":"Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: Results from the FHDH-ANRS CO4 cohort","volume":"60","author":"Grabar","year":"2015","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1086\/592692","article-title":"Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: A Danish population-based, nationwide cohort study","volume":"47","author":"Sogaard","year":"2008","journal-title":"Clin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"B9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/cid\/ciz728","article-title":"Incidence and risk factors for invasive pneumococcal disease and community-acquired pneumonia in human immunodeficiency virus-infected individuals in a high-income setting","volume":"71","author":"Garcia Garrido","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-018-0194-y","article-title":"Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells","volume":"15","author":"Nabatanzi","year":"2018","journal-title":"AIDS Res Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2848","article-title":"Microbial translocation in HIV infection: causes, consequences and treatment opportunities","volume":"10","author":"Sandler","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"103129","DOI":"10.1016\/j.ebiom.2020.103129","article-title":"Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection","volume":"62","author":"Novelli","year":"2020","journal-title":"eBioMedicine"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001645","article-title":"Natural killer cells in HIV-1 infection and therapy","volume":"31","author":"Mikulak","year":"2017","journal-title":"Aids"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000232231.34253.bd","article-title":"Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment","volume":"20","author":"Killian","year":"2006","journal-title":"Aids"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.9.4796","article-title":"Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in hiv-infected individuals","volume":"168","author":"Chehimi","year":"2002","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00753-09","article-title":"Impaired plasmacytoid dendritic cell (pdc)-nk cell activity in viremic human immunodeficiency virus infection attributable to impairments in both pdc and nk cell function","volume":"83","author":"Conry","year":"2009","journal-title":"J Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2009.03.003","article-title":"Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections","volume":"46","author":"Nowroozalizadeh","year":"2009","journal-title":"Cytokine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.cellimm.2008.01.007","article-title":"Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands","volume":"250","author":"Martinson","year":"2007","journal-title":"Cell Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e23884","DOI":"10.1371\/journal.pone.0023884","article-title":"Systemic immune activation in hiv infection is associated with decreased mdc responsiveness to tlr ligand and inability to activate naive cd4 t-cells","volume":"6","author":"Yonkers","year":"2011","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834f3167","article-title":"Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection","volume":"26","author":"Chang","year":"2012","journal-title":"Aids"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f4de35","article-title":"Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection","volume":"22","author":"Lester","year":"2008","journal-title":"Aids"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1086\/430931","article-title":"Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection","volume":"192","author":"Kamga","year":"2005","journal-title":"J Infect Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.4.2642","article-title":"Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in hiv-1-infected subjects undergoing antiretroviral treatment","volume":"179","author":"Chehimi","year":"2007","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.85433","article-title":"Innate immune reconstitution with suppression of HIV-1","volume":"1","author":"Scully","year":"2016","journal-title":"JCI Insight"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.03.002","article-title":"Functional analysis via standardized whole-blood stimulation systems defines the boundaries of a healthy immune response to complex stimuli","volume":"40","author":"Duffy","year":"2014","journal-title":"Immunity"},{"key":"B27","volume-title":"LMMstar: Repeated measurement models for discrete times","author":"Ozenne","year":"2021"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2016.00614","article-title":"Stimulation of PBMC and monocyte-derived macrophages via toll-like receptor activates innate immune pathways in HIV-infected patients on virally suppressive combination antiretroviral therapy","volume":"7","author":"Merlini","year":"2016","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000435603.50598.2b","article-title":"The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression","volume":"65","author":"Dillon","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00324-06","article-title":"Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type i interferons","volume":"80","author":"Tilton","year":"2006","journal-title":"J Virol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-018-0083-7","article-title":"Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection","volume":"12","author":"Guill\u00e9n","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1086\/651430","article-title":"Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections","volume":"201","author":"Nowroozalizadeh","year":"2010","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1097\/QAD.0b013e32833c93ce","article-title":"Immune activation, apoptosis, and treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy","volume":"24","author":"Piconi","year":"2010","journal-title":"Aids"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200201001-00009","article-title":"Endotoxin tolerance: A review","volume":"30","author":"West","year":"2002","journal-title":"Crit Care Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc5055","article-title":"Bench-to-bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis","volume":"10","author":"Cavaillon","year":"2006","journal-title":"Crit Care"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01600","article-title":"Development of endotoxin tolerance does not influence the response to a challenge with the mucosal live-attenuated influenza vaccine in humans in vivo","volume":"8","author":"Koch","year":"2017","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2334-12-5","article-title":"R-848 triggers the expression of TLR7\/8 and suppresses HIV replication in monocytes","volume":"12","author":"Nian","year":"2012","journal-title":"BMC Infect Dis"},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.157.4.1350","article-title":"A direct role for IFN-gamma in regulation of Th1 cell development","volume":"157","author":"Bradley","year":"1996","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw125","article-title":"Incidence of opportunistic infections and the impact of antiretroviral therapy among hiv-infected adults in low- and middle-income countries: a systematic review and meta-analysis","volume":"62","author":"Low","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(16)30216-8","article-title":"Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per \u03bcL: secondary outcome results from a randomised controlled trial","volume":"4","author":"O\u2019Connor","year":"2017","journal-title":"Lancet HIV"},{"key":"B42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2796.2008.02045.x","article-title":"NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection","volume":"265","author":"Alter","year":"2009","journal-title":"J Intern Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-004-6250-5","article-title":"Dendritic cell numbers in the blood of HIV-1 infected patients before and after changes in antiretroviral therapy","volume":"24","author":"Finke","year":"2004","journal-title":"J Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms8111787","article-title":"The role of toll-like receptors in retroviral infection","volume":"8","author":"Browne","year":"2020","journal-title":"Microorganisms"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/sji.13042","article-title":"Functional immune reconstitution early after allogeneic haematopoietic cell transplantation: A comparison of pre- and post-transplantation cytokine responses in stimulated whole blood","volume":"94","author":"Gj\u00e6rde","year":"2021","journal-title":"Scand J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1086\/529523","article-title":"Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4+ cell counts and HIV RNA levels during follow-up","volume":"197","author":"Lundgren","year":"2008","journal-title":"J Infect Dis"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.974767\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T01:35:17Z","timestamp":1676424917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.974767\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2022.974767"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.974767","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"article-number":"974767"}}